Better Prescribing Courtesy of Neurontin

Thanks to a big settlement back in 2004 over off-label marketing epilepsy drug Neurontin, there’s a new source of information about prescription drugs that isn’t funded directly by Big Pharma.
Run by the University of North Carolina and bankrolled with a chunk of the Neurontin settlement, Prescribing for Better Outcomes is poring over research on uses [...]